Latest filing published 02 May 2019 for Nautilus, INC..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Ronald P. Badie span 5 companies, the busiest being Amphenol Corp /DE/, Nautilus, Inc. and Obagi Medical Products, Inc. The record holds 55 filings, for trades running from 3 January 2006 to 30 April 2019.
On the open market, the record shows 5 purchases worth €112k and 9 sales worth €6.0M. The net balance comes to €5.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 26 share grants and 13 option exercises.
The median purchase comes to €21k.
The latest filing, published on 2 May 2019, reports a share grant in Nautilus, Inc. The most recent open-market purchase was published on 29 October 2008, 6,569 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 49 declarations